CARCINOGEN-INDUCED TUMORS OF THE THYMUS : IV. HUMORAL INFLUENCES OF NORMAL THYMUS AND FUNCTIONAL THYMOMAS AND INFLUENCE OF POSTTHYMECTOMY PERIOD ON RESTORATION by Stutman, Osias et al.
CARCINOGEN-INDUCED  TUMORS  OF  THE THYMUS 
IV.  HUMORAL  INZ~LUENCES OF NOR~.~ Tmn~us AND FUNCTIONAL THYMOMAS 
AND  INYLUENCE OF POSTTHYMECTOMY  PERIOD ON  RESTORATION* 
BY OSIAS STUTMAN, M.D., EDMOND J. YUNIS, M.D., A~¢O ROBERT A. GOOD, M.D. 
(From tke Depargn~ts of Laboratory Medicine, Pediatrics, and Microbiology, Uniz~rsity 
of Minnesota Medical School, Minneapolis,  Minnesota  55455) 
(Received for publication 7 May 1969) 
Studies  with  functional  nonlymphoid  thymomas  showed  that  when  the 
tumors were grafted into neonatally thymectomized aUogeneic hosts, immuno- 
logical restoration was mediated by the host's own lymphoid cells (1). Compara- 
ble results had been previously reported with thymus grafts (2-6), while spleen 
cells produced adoptive restoration mediated by donor cells (4, 7). It was sug- 
gested that the tumoral nonlymphoid stroma of the thymus may act in an in- 
direct way inducing differentiation and/or expansion of a population of poten- 
tially competent ceils in the lymphoid tissues of thymectomized hosts (1). This 
hypothesis was supported by evidence of the functional capacity of the thy- 
momas when enclosed in cell-impenetrable diffusion chambers (8). 
In a preliminary report (9), we observed a decrease of the restorative capacity 
of a functional thymoma in neonatally thymectomized conventional mice when 
the treatment was  delayed after thymectomy. Treatment became ineffective 
when performed at 50 days of age or later. These results suggested that a popu- 
lation of cells in the tissues of the thymectomized hosts, capable of responding to 
the inductive or expanding action of the thymoma, decreased progressively with 
time after neonatal thymectomy in the absence of thymic function. Our present 
results also indicate that with delay of the treatment a  similar decrease in re- 
storing capacity was observed when thymus grafts, thymus in diffusion cham- 
bers, and thymomas alone or in diffusion chambers were used. 
Materials and Methods 
Animals.--Inbred mice of the A, C3Hf/Bi, DBA/2, and C57BL/1 strains were used. Strain 
details and animal care were described  in a previous  paper (1). 
Tecknlcal Procedures.--The techniques for neonatal thymectomy, thymoma and thymus 
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grafting, skin grafting, cell suspension preparation, and delayed hypersensitivity reactions to 
sheep red cells have been described in previous publications (1, 8). 
Diffusion chambers were prepared with lucite rings and Millipore diffusion filters of 0.22 # 
average pore size (Millipore Filter Corp.,  Bedford,  Mass.).  Details and  descriptions of the 
chambers have been reported previously (8). 
Graft-versus-host assays were performed using 10  X  106 spleen cells from the C3Hf/Bi 
donors injected intraperitoneally into  8-day old (C3I-IxC57BL/1)F1  hybrids.  Spleen indices 
were obtained 8 days later as described in previous publications (1, 7). 
Nonlymphoid Functional Thymomas.--Two  nonlymphoid functional thymomas  of A  and 
C3H/Bi origin were used. The tumors were found 200 days after intrathymic application at 
birth of 0.1 mg of 7, 12-dimethylbenzanthracene: When used in the present experiments, the 
thymoma A was in its fifth transplant generation and the thymoma C3H/Bi was in its third 
generation. Description of the morphological and functional characteristics of these thymomas 
have been reported previously (1, 8). The A sarcoma of the A strain used as control in some 
experiments (Table VII and VIII) was a nonfunctional mediastinal sarcoma obtained 200 days 
after intramediastinal injection at birth of 0.1 mg of 7, 12-dimethylbenzanthracene; it was in 
its fourth transplant generation. Thymus graft donors were always 20-day old male and female 
mice. 
Restoration Criteria.--We  considered neonatally thymectomized animals to have been re* 
stored by the different treatments if they fulfilled the following criteria (for restoration) : Ca) 
complete thymectomy at the termination of the experiment (microscopic analysis of the medias- 
tinal contents); (b) 200 day survival; (c) capacity to reject DBA/2 ~kln grafts in less than 15 
days when tested at 90-100 days of age; (d) capacity to produce delayed hypersensitivity to 
sheep red cells when tested at 150-160  days of age; and  (e) capacity of their spleen cells to 
initiate graft-versus-host reactions when injected into adequate F1 hybrids. The presence of all 
five criteria were essential for considering a particular animal restored. 
Experimengal Designs.-- 
E.~e~t of age a~ grafgng: Neonatally thymectomized A or C3Rf/Bi mice were grafted with 
thymus or thymomas at different time intervals after thymectomy, ranging from 5 to 50 days 
(see Tables I-IV). Restoration was indicated by the five criteria mentioned earlier. The follow- 
ing experiments were performed: (a) neonatally thymectomized A mice grafted subcutaneously 
at different ages with A thymus orA thymoma (TableI); (b) neonatMly thymectomized C3Hf/ 
Bi mice grafted subcutaneously at different ages with C3Hf/Bi, (C3HxA)F1 or A thymus, or 
with A thymoma (Table II); (~) neonatMly thymectomized C3Hf/Bi mice grafted intraperi- 
toneally at different ages with C3Rf/Bi or A thymus, or with A or C3H/Bi thymomas enclosed 
within cell-impermeable diffusion  chmnbers (Table IV). 
At~mpts to reverse the postthymeaomy-wasting syndrome: As in previous publications (5, 7), 
wasting was defined by a decrease of at least 10% body weight or by a failure to gain weight 
for at least 10 days after reaching a certain level. Treatments were performed I day after clear- 
cut evidence of wasting syndrome was obtained in conventional neonatally thymectomized 
C3Hf/Bi or A mice. Wasting appeared at approximately 60-85 days of age. Restoration criteria 
were similar to those previously described, except that delayed hypersensitivity tests were not 
done in the present group of experiments. The following experiments were performed:  (a) 
wasted C3Rf/Bi or A mice grafted with one or five subcutaneous or intraperitoneal thymus 
grafts of C3Rf/Bi or A origin, or with subcutaneous strain A thymoma grafts (Table V); (b) 
consisted of the same model except that thymuses or thymomas of A or C3H/Bi origin were 
implanted intraperitoneMly within cell-impermeable diffusion chambers (Table VI); (c) wasted 
A mice treated with (i) subcutaneous grafts of A thymoma or A sarcoma,  (ii) intraperitoneal 
injection of 200  X  106 spleen cells from 5-day old or 45-day old neonatally thymectomized A 
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(Table VII); (iv) wasted C3HI/Bi mice treated with: subcutaneous grafts of A thymoma or A 
sarcoma; intraperitoneal injection  of 200 or 400 X 10  6 spleen  cells  from 5-day old or 45-day  old 
neonatally thymectomized C3Hf/Bi mice; and a combination of subcutaneous tumors and 
intraperitoneal spleen cells (Table VIII). 
RESULTS 
Effect of Age at Treatment.--Table  I shows the influence of delaying treatment 
after neonatal thymectomy in strain A mice on the restorative capacity of syn- 
geneic functional thymoma and thymus grafted subcutaneously. A progressive 
TABLE I 
E.ffect of Age at Treatmen~ on Restoration of Neonatally  Thym~tomlzed  Strain A  Mice urltk 
Syngene~ Tkymoma or Thymus Subcutaneous Grafts 
Age at grafting* 
Number restored per number treated:[: 
A thymoma  A thymus 
~ys  %  % 
5  16/20 (8O)  8/10  (80) 
lO  9/lO  (9o)  8/10  (8o) 
15  16/24  (66)  9/12  (75) 
20  11/17  (64)  7/8  (87) 
30  8/20  (40)  8/13  (6i) 
40  7/30  (25)  7/12  (58) 
45  6/32  (18)  5/12  (41) 
50  2/15  (13)  5/16  (31) 
* Subcutaneous grafting of 1 X l0  s thymoma cells or one thymus from 20-day old donors 
For restoration criteria see text. 
decrease in effectiveness was observed when treatments were delayed. When 
grafting was performed between 5  and 20 days after neonatal thymectomy, 
restoration was observed in 72 %  (52/71) mice treated with thymoma and 80 % 
(32/40) mice treated with thymus. By contrast, when grafting was performed 
between 30 and 50 days after thymectomy, restoration was observed in 23 % 
(23/97) mice treated with thymoma and 47 %  (25/53) mice grafted with thy- 
mus.  Comparable results are shown in Table II, when neonataUy thymecto- 
mized C3Hf/Bi mice were grafted subcutaneously with syngeneic, hemiallo- 
geneic, and allogeneic thymus grafts, or with the functional strain A thymoma. 
Restoration was observed in 75 % (70/93) treated with syngeneic thymus at 5- 
20 days of age and 46 %  (37/80) treated with syngeneic thymus at 30--50 days 
of age. When the animals were grafted with (C3HxA)F1 thymus, 62 %  (25/40) 
mice were restored when grafted at 5-20 days and 26% (15/56)  were restored 
when grafted at 30-50 days of age. Allogeneic A strain thymus was less effective 
and only 24% (12/46) animals were restored when grafted at 5-20 days of age 
and 9 %  (6/66) when treated at 30-50 days of age. Restoration with the func- 812  CARCINOGEN-INDUCED  TUMORS  OF  THE  THYMUS 
tional strain A thymoma was 65 % (82/126) for the groups grafted at 5-20 days 
and 22%  (32/148)  for the groups grafted at 30-50 days of age. These results 
indicate that a progressive decrease on the restorative capacity of syngeneic or 
TABLE  II 
Effect  of Age at Treatment  on Restoration  of Neonatally  Thymutomized C3Hf/Bi Mice wittt 
Allogeneic  Thymoma or Syngenei¢ or Allogeneic  Thymus Subcutaneous  Grafts 
Age at 
grafting* 
Number restored per number treated~ 
C3Hf/Bi thymus  (C3HxA)Fa  thymus  A thymus  A thymoma 
days  %  %  %  % 
5  16/20  (80)  ND§  3/10  (30)  22/30  (73) 
10  16/20  (80)  9/12  (75)  3/12  (25)  16/20  (80) 
15  18/24  (75)  8/14  (57)  3/12  (25)  22/40  (55) 
20  12/16  (75)  8/14  (57)  3/12  (25)  10/16  (62) 
25  8/13  (61)  ND  ND  12/20  (60) 
30  16/26  (61)  6/12  (50)  3/16  (18)  11/45  (24) 
35  8/14  (57)  ND  2/14  (14)  8/20  (40) 
40  6/12  (50)  5/14  (35)  1/12  (8)  7/30  (23) 
45  4/12  (33)  3/14  (20)  0/12  5/35  (14) 
50  3/16  (18)  1/16  (6)  0/12  1/18  (5) 
* Subcutaneous grafting of 1 X 106 thymoma cells or one thymus from 20-day old donors. 
For restoration criteria see text. 
§ ND, not done. 
Effext  of Age at  Treatment  on 
TABLE  III 
Restoration  of Neoncgally  Thymeaomized C3Hf/Bi Mice with 
Intraperitoneal  Thymus Grafts 
Age at  Number restored per number treated:[: 
treatment*  C3Hf/Bi thymus  (C3HxA)FI thymus  A thymus 
days  %  %  % 
lO  8/10  (8o)  8/10  (80)  3/10  (30) 
20  8/10  (80)  8/10  (80)  3/10  (30) 
30  10/12  (83)  9/13  (69)  3/12  (25) 
40  6/10  (60)  5/10  (50)  0/10 
50  3/10  (30)  3/10  (30)  0/10 
* Intraperitoneal grafting of one thymus from 20-day old donors. 
For restoration criteria see text. 
aUogeneic thymus or thymoma grafts takes place when the treatment is delayed 
after neonatal thymectomy. 
When syngeneic or allogeneic thymus grafts were implanted intraperitoneally 
in neonatally thymectomized C3Hf/Bi mice, comparable decrease in effective- 
ness was observed (Table III). 
When  syngeneic or allogeneic thymus grafts or functional  thymomas were OSIAS STUTMAN, EDMOND J.  YUNIS~ AND  ROBERT A.  GOOD  813 
grafted intraperitoneaUy within cell-impenetrable diffusion chambers in neona- 
tally thymectomized C3Hf/Bi mice, a marked decrease in effectivity was ob- 
served when the treatment was performed after 25 days of age (Table IV). When 
treatment was performed at 10-20 days, restoration was observed in 40% (17/ 
42) mice treated with syngeneic C3Hf/Bi thymus, 39%  (17/43)  treated with 
allogeneic A thymus, 65 % (39/60)  grafted with syngeneic C3H/Bi thymoma, 
and 56 % (24/43)  animals grafted with allogeneic strain A thymoma. When the 
TABLE  IV 
Effect of Age at  Treatment on Restoration of Neonatally  Thymectomized C3H//Bi Mice with 
Inlraperiloneal Diffusion Chambers Containing Thymus or Thymoma Grafts 
Number restored  per number  treated~ 
Age at 
grafting*  C3Hf/Bi  Empty  thymus  A thymus  C3Hf/Bi  thymoma  A thymoms  chamber 
days  %  %  %  % 
10  7/14  (50)  7/13  (53)  13/20  (65)  8/12  (66)  0/10 
15  7/15  (46)  7/15  (46)  13/65  (65)  8/15  (53)  0/12 
20  3/13  (23)  3/15  (20)  13/20  (65)  8/16  (50)  0/10 
25  2/12  (16)  1/12  (8)  6/22  (27)  2/10  (20)  0/10 
30  1/12  (8)  0/20  3/14  (21)  6/22  (27)  0/15 
35  1/12  (8)  0/12  0/12  3/14  (21)  0/10 
40  0/12  1/19  (5)  0/13  3/14  (21)  0/10 
45  0/12  0/12  0/15  1/17 (5)  0/5 
50  0/12  0/15  0/13  0/12  0/5 
* Intraperitoneal implantation of diffusion chambers (lucite rings with 0.22 tt average pore 
size filters) containing 2 X 2 mm fragments of thymomas or thymus from 20-day old donors. 
For restoration criteria see text. 
TABLE V 
RcversaI of Postthymeclomy Wasting in Neonatally Thymectomized C3Hf/Bi and A  Mice with 
Thymus or Thymoma Grafts 
Treatment*  Route 
Restoratlon$ 
C3Hf/Bi  A 
%  % 
1 thymus C3Hf/Bi  s.c.  0/42  0/14 
1 thymus A  s.c.  0/11  0/28 
5 thymuses C3Hf/Bi  s.c.  13/60  (21)  4/40  (10) 
5 thymuses A  s.c.  4/40  (10)  5/26  (19) 
Thymoma A  s.c.  0/49  0/48 
1 thymus C3Hf/Bi  i.p.  2/32  0/10 
1 thymus A  i.p.  0/12  1/22  (4) 
5 thymuses C3Hf/Bi  i.p.  19/29  (65)  4/41  (9) 
5 thymuses A  i.p.  4/21  (19)  3/29  (10) 
* Grafting performed subcutaneously or intraperitoneafly after onset of wasting. 
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treatment was performed  at 25-50 days of age, restoration decreased  to 5 % 
(4/72)  for the syngeneic thymus group,  2 % (2/90)  for the aUogeneic thymus 
group,  10% (9/89)  for the syngeneic thymoma group, and 16% (15/89) for the 
allogeneic thymoma group.  The decrease in  effectiveness of the treatments, 
when delayed after neonatal thymectomy  is more accentuated when thymus or 
thymomas are implanted within cell-impenetrable diffusion chambers. 
Attempts  to  Reverse  Postthymectomy  Wasting.--Neonatally  thymectomized 
C3Hf/Bi and A mice were  treated after the onset of the postthymectomy- 
wasting syndrome, generally at 55-75 days of age. As reported previously (5), 
TABLE VI 
Attempts to Reverse Posttkymeaomy Wasting in Neonatally Thymeaoraized C31tf/Bi  and A 
Mice with Thymus or Tkymomas in Diffusion Chambers 
Treatment* 
Restoration~ 
C3Hf/Bi  A 
Empty diffusion chamber  0/10  0/11 
1 thymus  C3Hf/Bi  0/19  0/13 
1 thymus  A  0/12  0/13 
5 thymuses  C3Hf/Bi  0/43  0/29 
5 thymuses  A  0/20  0/21 
Thymoma  C3H/Bi  0/37  0/10 
Thymoma  A  0/30  0/33 
* Intraperitoneal implantation  of diffusion  chambers (lucite rings and 0.22 # Millipore 
filters) after  onset  of wasting. Thymus  donors  were  20-day  old normal  females. 
~t Number  restored  per number  treated. For restoration  criteria  see text. 
Table V  shows  that when grafted subcutaneously or  intraperitoneally, five 
thymuses of syngeneic origin and to less degree of allogeneic strains can reverse 
the wasting syndrome after its onset. One thymus graft is usually ineffective. 
Thymoma grafts in syngeneic or allogeneic host mice with wasting disease were 
ineffective (Table V). Table VI shows that one  thymus, multiple thymuses or, 
functional thymomas of syngeneic or allogeneic origin enclosed in cell-impene- 
trable diffusion chambers are incapable of reversing the postthymectomy  wast- 
ing after its onset. All animals died 5-45 days after the treatment was performed 
and showed no restoration of immunological responses. 
Effect  of Spleen Cells from  Thymectomized  Donors.--Table VII shows that 
wasted A mice could be restored only with intraperitoneal spleen cells from 5- 
day old neonatally thymectomized syngeneic donors in combination with sub- 
cutaneous grafts of the strain A functional thymoma. Spleen cells from 45-day 
old neonatally thymectomized  donors were ineffective. Table VIII shows similar 
experiments performed in wasted C3Hf/Bi mice. As in the previous experiments, 
spleen cells from 5-day old neonatally thymectomized  syngeneic donors injected 
intraperitoneally were effective in reversing the wasting when associated  with OSIAS  STUTMAN,  EDMOND  J.  YUNIS, AND  ROBERT  A.  GOOD  815 
subcutaneous grafts of the functional strain A thymoma. Spleen cells from 45- 
day old neonatally thymectomized donors in association  with thymoma grafts 
were ineffective.  In both types of experiments thymoma grafts alone, spleen 
cells, or spleen cells in association with a nonfunctional strain A sarcoma were 
TABLE  VII 
AUemp~s to Reverse  Postthymectomy Wasting Cn Neona~ally Thymectomized  A Mice with Strain 
A  Thymoma  and Spleen Cells  from Neonatally Thymectomized Strain A Mice 
Treatment performed after onset of wasting, approximately at 40--60 days of age. 
Tumor graft*  Spleen cells~  Age of spleen  Number restored per  cell donors  number treated 
XI06  days  % 
A thymoma  None  --  0/16 
A  sarcoma  None  --  0/13 
None  None  ~  0/12 
None  200  5  0/12 
None  200  45  0/12 
A thymoma  200  5  4/14  (28) 
A thymoma  200  45  0/24 
A sarcoma  200  5  0/11 
* Subcutaneous injection of I X  l0  s tumor cells. 
:~ Intraperitoneal injection of spleen cells from neonatally thymectomized strain A mice of 
5 or 45 days of age. 
TABLE  VIII 
Attempts to Reverse  PosUhymectomy Wasting in Neonatally Thymectomized  C3Hf/Bi M@e with 
Strain A Thymoma and Spleen Cells  from Nevnatally Thymectomized C3Hf/Bi Mice 
Treatment performed after onset of wasting, approximately at 40-60 days. 
Tumor graft*  Spleen cells:~  Age of  Number restored per  cell donor  number treated 
X106  day~  % 
A thymoma  None  --  0/25 
A sarcoma  None  --  0/12 
None  None  --  0/30 
None  200  5  0/13 
None  400  5  0/29 
None  400  45  0/21 
A sarcoma  200  5  0/13 
A sarcoma  400  45  0/11 
A thymoma  200  5  6/20 
A thymoma  400  5  6/19 
A thymoma  200  45  0/19 




* Subcutaneous injection of 1 X  l0  s tumor cells. 
Intraperitoneal injection of spleen cells from neonatally thymectomized C3Hf/Bi mice 
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ineffective in reversing the wasting syndrome after its onset.  Further, they were 
unable to induce restoration of any of the parameters studied. 
DISCUSSION 
Restoration of neonataUy thymectomized mice with thymus grafts suggested 
that the thymus is acting in an indirect way, since all the immunocompetent 
cells are derived  from the host (2-6).  Comparable  results were obtained with 
functional thymomas (1), or thymus, or thymomas within cell-impenetrable 
diffusion chambers. 1  The cell-impenetrable chamber  experiments suggested that 
the thymus may act by means of a humoral diffusible factor (10). Other mecha- 
nisms of thymic function include  a  traffic through thymic stroma of cells of 
hemopoietic origin (11) and a seeding out of a thymus-derived cell population 
to the peripheral lymphoid tissue (12). The three possible mechanisms of thymic 
action are not mutually exclusive, although the quantitative contribution of 
each component under physiological conditions is unknown. It would seem from 
our present results that two factors are necessary for normal development and 
continued function of the thymus: an intact reticuloepithelial  framework,  re- 
lated to the inductive function; and a supply of "stem" cells, probably of hemo- 
poietic origin, sensitive to the inductive action of the thymus. 
Our present results can be summarized as follows: (a) there is a progressive 
decrease  of restorative effectiveness of thymoma or thymus grafts when the 
treatment of neonatally thymectomized mice is delayed; (b) early restoration 
between 5 and 20 days after thymectomy is effective, while the number of re- 
stored animals is markedly decreased following attempts to achieve restoration 
between 30 and 50 days postthymectomy; (c) comparable  results are obtained 
with subcutaneous grafts, intraperitoneal grafts, or grafts within cell-impene- 
trable diffusion chambers  (Tables I-IV). It is possible that the population of 
cells capable of responding to the inductive action of the thymoma or thymus in 
diffusion chambers may represent a population that received "thymic  influence" 
before thymectomy was performed,  and that the humoral function of the thy- 
mus can expand solely such population of "postthymic" cells in the peripheral 
tissues of the host (13). In mice reared  in conventional environment, the decay 
of the postthymic cells with time may be partly explained by an exhaustion due 
to lack of replacement  in absence of thymic function and/or through commit- 
ment to immunological functions. 
A decrease in effectiveness, although less marked, was observed when syn- 
geneic thymus grafts were used (Table I-III), indicating that the difference 
may be due to the thymic stroma itself. It can be theorized that the population 
of "postthymic" cells arises through a traffic of bone marrow cells to the thy- 
mus, and that only normal syngeneic thymus (as opposed to allogeneic thymus, 
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thymomas, or thymus in diffusion chambers) can provide optimal conditions 
for traffic of cells of hemopoietic origin and for the building up of a population 
of "postthymic" cells capable of response to the inductive or expanding humoral 
activity of the thymus (13). The comparison between spleen cells from 5-day old 
and 45-day old neonatally thymectomized  mice for their capacity to reverse the 
postthymectomy-wasting syndrome when given in association  with thymoma 
grafts also indicates that a population of cells sensitive  to the function of the 
thymoma is present in the spleen cells of 5-day old thymectomized  mice and is 
absent in the spleen cells from 45-day old neonatally thymectomized hosts 
(Tables VII and VIII). All these results are compatible with the view that a 
special cell is present in the peripheral tissues of the neonatally thymtecomized 
host. This special cell is sensitive to the inductive or expanding action of the 
thymus. This intermediate cell requires the presence of the thymus for renewal 
of its population and will decrease progressively in absence of thymic function. 
Additional experiments (13) indicate that this type of cell is already present in 
lymphohemopoietic tissues  of newborn mice but is absent in the hemopoietic 
tissues of embryonic mice. The difference between the "embryonic" and "new- 
born" type of cell is that the latter is sensitive to the humoral action of the 
thymus (thymoma or thymus in diffusion chambers), while the former needs the 
normal thymic stroma to achieve the state of immunological competence. This 
suggests that thymus traffic must occur for this influence to be exercised (13). 
The effect of allogeneic thymus grafts (Tables II and III) is comparable to 
previous experiments, suggesting that differences in influence between allogeneic 
and syngeneic or F1 hybrid parent combinations may be attributed to a graft- 
versus-host reaction (4-6, 14). 
The experiments on reversal of the postthymectomy-wasting syndrome de- 
serve comment. Wasting in thymectomized mice can be prevented or delayed 
under germfree conditions, suggesting that environmental factors influence the 
pathogenesis of this syndrome (15). However, the wasting model is still of im- 
portance since it mimics dramatically the syndrome observed in the human 
lymphopenic states (16,  17). In previous publications we showed that the post- 
thymectomy  syndrome could be easily reversed adoptively with immunocompe- 
tent cells, and that multiple thymus grafts could also  effectively reverse the 
syndrome and restore such animals to health and immunologic competence (4, 5, 
7).  Thymus grafts showed that restoration was eventually mediated by the 
host's own lymphoid cells (5). The present results confirm previous finding (5, 
18), showing that the only effective treatment with thymus grafts of the post- 
thymectomy wasting after its onset was the implantation of multiple thymus 
grafts (Table V). On the other hand, Table VI shows that when only the hu- 
moral activity of the thymus was employed (multiple thymuses or thymoma in 
diffusion chambers), no reversal of the wasting syndrome was observed. These 
results suggest that an initial "cellular" stage is needed for the reversal of the 818  CARCINOGEN-INDUCED TUMORS OF THE THYMUS 
syndrome. This cellular stage could be represented  by a component of thymus- 
derived cells (12) and/or by traific of host cells through the thymus grafts (11). 
The quantitative difference between multiple and single thymus grafts may be 
due to the acuteness  of the disease and the marked decrease of "postthymic" 
cells with time after thymectomy. This difference is indicated in experiments 
reported here. One article in which postthymectomy  wasting was reversed with 
multiple thymus grafts within diffusion chambers in 35 % of the treated animals 
has been presented (19). Timing of the treatment, strain variations, environ- 
mental factors, restoration criteria,  and techniques used for construction of the 
chambers (0.30 as opposed to 0.22 # mean pore size filters) could easily account 
for the difference in results. The two last points may be important since (a) our 
restoration criteria,  besides survival, include the return to normal of two im- 
munological parameters in the same animal; and (b) our report states that the 
0.30/z mean pore size permits some cell traffic across the filters (8). 
SU~r~Ry 
A progressive decrease of the restoring  effectivity of syngeneic or allogeneic 
thymus and functional thymoma grafts was observed  when the treatment of 
neonatally thymectomized mice was delayed. Early treatment (5-20 days post- 
thymectomy) was effective, while the number of restored animals was markedly 
decreased  after late treatment (30-50 days postthymectomy). Similar results 
were obtained with subcutaneous or intraperitoneal thymus grafts and  with 
thymus grafts within cell-impenetrable  diffusion chambers.  After the onset of 
the postthymectomy-wasting  syndrome the only successful treatment was  the 
implantation of multiple thymus grafts. On the other hand,  single  thymus 
grafts, thymoma grafts, or thymus or thymoma within diffusion chambers  were 
ineffective. When spleen cells from 5-day old or 45-day old neonatally thymec- 
~.omized animals were given in association with thymoma grafts, only the cells 
derived from the 5-day old thymectomized mice proved effective in  restoring 
wasted thymectomized hosts.  These results suggest that a population of cells 
sensitive  to the action of the thymus decreases progressively with time in the 
absence of thymic function. 
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their able assistance. 
BIBLIOGRAPHY 
1.  Stutman, 0., E. J. Yunis, and R. A. Good. 1958. Carcinogen-induced  tumors of the 
thymus. I. Restoration of neonatally thymectomized mice with a functiona| 
thymoma. J. Nat. Cancer. I~t. 41:1431. 
2. Dalmasso,  A. P., C. Martinez, K. Sjodin, and R. A. Good. 1953. Studies on the role 
of the thymus in immunobiology.  Reconstitution of immunologic  capacity in 
mice thymectomized  at birth. Y. Exp. Med. 118:1089. OSIAS STUTMAN, EDMOND J.  YUNIS, AND ROBERT A.  GOOD  819 
3.  Miller,  J.  F.  A.  P.  1964. Effect  of  thymic  ablation  and  replacement.  In 
The Thymus in Immunobiology. R. A.  Good and A.  E.  Gabrielsen,  editors. 
Hoeber-Harper. New York. 436. 
4.  Yunis, E. J., H. R. Hilgard, C. Martinez, and R. A. Good.  1965. Studies  on im- 
munologic reconstitution of thymectomized mice. J. Exp. Med. 121:607. 
5.  Stutman, O., E. J. Yunis, C. Martinez, and R. A. Good,  1967. Reversal of post- 
thymectomy wasting disease in mice by multiple thymus grafts. J. Immunol. 
98:79. 
6.  Stutman, O., E. J. Yunis, and R. A. Good. 1969. Tolerance induction with thymus 
graft in neonataUy thymectomized mice. J. Immunol.  103:92. 
7.  Stutman, O., E. J. Yunis, and R. A. Good.  1969. Reversal of post-thymectomy 
wasting in mice with immuno-competent cells: Influence of histocompatibility 
differences. J. Immunol.  102:87. 
8.  Stutman, O., E. J. Yunis, and R. A. Good. 1969. Carcinogen-induced  tumors of the 
thymus. III. Restoration of neonataUy thymectomzed mice with thymomas in 
cell impermeable chambers. J. Nat. Cancer Inst. 48:499. 
9.  Stutman, O., E. J. Yunis, and R. A. Good. 1967. Effect of age at grafting on pro- 
tection of thymectomized mice with thymic tumor. Proc. Amer.  Ass. Cancer. 
Res. 8:65. 
10.  Osoba,  D.  1965. The effects  of thymus and other lymphoid organs enclosed  in 
Millipore diffusion chambers on neonatally thymectomized mice. ]. Exp. Med. 
122:633. 
11.  Ford, C. E. 1966. Traffic of lymphoid cells in the body. In Ciba Foundation Sym- 
posium, The Thymus: Experimental and Clinical  Studies.  G. E. W. Wolsten- 
hoime and R. Porter, editors. Little, Brown and Co. Boston. 131. 
12.  Davies, A. J. S., E. Leuchars, V. Wallis, and P. C. Koflers. 1966. The mitotic re- 
sponse of thymus derived cells to antigenic stimulus. Transplantation. 4::438. 
13.  Stutman, O., E. J. Yunis, and R. A. Good. 1969. Thymus: An essential factor in 
lymphoid repopulation. Transplant Proc. 1:614. 
14.  Stutman, O., E. J. Yunis, P. O. Teague, and R. A. Good. 1968. Graft-versus-host 
reactions induced by transplantation of parental strain thymus in neonatally 
thymectomized F1 hybrid mice. Transplantation. 6:514. 
15.  Mclntire, K. R., S. Sell, and J. F. A. P. Miller.  1964. Pathogenesis of the post- 
neonatal thymectomy wasting syndrome. Nature (London). 9.04:151. 
16.  Hoyer, J. R., M. D. Cooper, M. A. Gabrielsen,  and R. A. Good.  1968. Lympho- 
penic forms of congenital immunologic deficiency diseases. Medicine. 4:7:201. 
17.  Bergsma, D., and R. A. Good, editors.  1968. Birth defects.  In ImmunologicDe- 
ficiency Diseases in Man. The National Foundation, New York. 4::(1). 
18.  Schaller,  R. T., J. Schaller,  and J. K. Stevenson. 1967. Reversal of wasting syn- 
drome in thymectomized mice by multiple syngeneic or allogeneic thymus grafts. 
J. Nat. Cancer. Inst.  88:287. 
19.  Schaller, R. T., and J. K. Stevenson. 1967. Reversal of post-thymectomy wasting 
syndrome with multiple thymus grafts in diffusion  chambers. Proc. Soc. Exp. 
Biol. Med. 124:199. 